Report error Found 140 Enz. Inhib. hit(s) with all data for entry = 13235
TargetNuclear receptor subfamily 1 group I member 2(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
Affinity DataIC50: 3nMAssay Description:PXR can be determined in an in vitro assay system. Such in vitro assay systems include assay such as the assays as described herein.More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group I member 2(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
Affinity DataIC50: 3.80nMAssay Description:PXR can be determined in an in vitro assay system. Such in vitro assay systems include assay such as the assays as described herein.More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group I member 2(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
Affinity DataIC50: 4.40nMAssay Description:PXR can be determined in an in vitro assay system. Such in vitro assay systems include assay such as the assays as described herein.More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group I member 2(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
Affinity DataIC50: 6.20nMAssay Description:PXR can be determined in an in vitro assay system. Such in vitro assay systems include assay such as the assays as described herein.More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group I member 2(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
Affinity DataIC50: 6.20nMAssay Description:PXR can be determined in an in vitro assay system. Such in vitro assay systems include assay such as the assays as described herein.More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group I member 2(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
Affinity DataIC50: 7.20nMAssay Description:PXR can be determined in an in vitro assay system. Such in vitro assay systems include assay such as the assays as described herein.More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group I member 2(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
Affinity DataIC50: 7.40nMAssay Description:PXR can be determined in an in vitro assay system. Such in vitro assay systems include assay such as the assays as described herein.More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group I member 2(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
Affinity DataIC50: 7.5nMAssay Description:PXR can be determined in an in vitro assay system. Such in vitro assay systems include assay such as the assays as described herein.More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group I member 2(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
Affinity DataIC50: 7.60nMAssay Description:PXR can be determined in an in vitro assay system. Such in vitro assay systems include assay such as the assays as described herein.More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group I member 2(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
Affinity DataIC50: 7.60nMAssay Description:PXR can be determined in an in vitro assay system. Such in vitro assay systems include assay such as the assays as described herein.More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group I member 2(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
Affinity DataIC50: 7.80nMAssay Description:PXR can be determined in an in vitro assay system. Such in vitro assay systems include assay such as the assays as described herein.More data for this Ligand-Target Pair
3D Structure (crystal)TargetNuclear receptor subfamily 1 group I member 2(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
Affinity DataIC50: 8.5nMAssay Description:PXR can be determined in an in vitro assay system. Such in vitro assay systems include assay such as the assays as described herein.More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group I member 2(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
Affinity DataIC50: 11.9nMAssay Description:PXR can be determined in an in vitro assay system. Such in vitro assay systems include assay such as the assays as described herein.More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group I member 2(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
Affinity DataIC50: 12nMAssay Description:PXR can be determined in an in vitro assay system. Such in vitro assay systems include assay such as the assays as described herein.More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group I member 2(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
Affinity DataIC50: 13nMAssay Description:PXR can be determined in an in vitro assay system. Such in vitro assay systems include assay such as the assays as described herein.More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group I member 2(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
Affinity DataIC50: 14nMAssay Description:PXR can be determined in an in vitro assay system. Such in vitro assay systems include assay such as the assays as described herein.More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group I member 2(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
Affinity DataIC50: 14.7nMAssay Description:PXR can be determined in an in vitro assay system. Such in vitro assay systems include assay such as the assays as described herein.More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group I member 2(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
Affinity DataIC50: 15nMAssay Description:PXR can be determined in an in vitro assay system. Such in vitro assay systems include assay such as the assays as described herein.More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group I member 2(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
Affinity DataIC50: 16nMAssay Description:PXR can be determined in an in vitro assay system. Such in vitro assay systems include assay such as the assays as described herein.More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group I member 2(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
Affinity DataIC50: 16nMAssay Description:PXR can be determined in an in vitro assay system. Such in vitro assay systems include assay such as the assays as described herein.More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group I member 2(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
Affinity DataIC50: 16nMAssay Description:PXR can be determined in an in vitro assay system. Such in vitro assay systems include assay such as the assays as described herein.More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group I member 2(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
Affinity DataIC50: 17nMAssay Description:PXR can be determined in an in vitro assay system. Such in vitro assay systems include assay such as the assays as described herein.More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group I member 2(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
Affinity DataIC50: 17.7nMAssay Description:PXR can be determined in an in vitro assay system. Such in vitro assay systems include assay such as the assays as described herein.More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group I member 2(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
Affinity DataIC50: 18nMAssay Description:PXR can be determined in an in vitro assay system. Such in vitro assay systems include assay such as the assays as described herein.More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group I member 2(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
Affinity DataIC50: 18nMAssay Description:PXR can be determined in an in vitro assay system. Such in vitro assay systems include assay such as the assays as described herein.More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group I member 2(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
Affinity DataIC50: 19nMAssay Description:PXR can be determined in an in vitro assay system. Such in vitro assay systems include assay such as the assays as described herein.More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group I member 2(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
Affinity DataIC50: 19nMAssay Description:PXR can be determined in an in vitro assay system. Such in vitro assay systems include assay such as the assays as described herein.More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group I member 2(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
Affinity DataIC50: 19nMAssay Description:PXR can be determined in an in vitro assay system. Such in vitro assay systems include assay such as the assays as described herein.More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group I member 2(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
Affinity DataIC50: 20nMAssay Description:PXR can be determined in an in vitro assay system. Such in vitro assay systems include assay such as the assays as described herein.More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group I member 2(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
Affinity DataIC50: 20nMAssay Description:PXR can be determined in an in vitro assay system. Such in vitro assay systems include assay such as the assays as described herein.More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group I member 2(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
Affinity DataIC50: 21nMAssay Description:PXR can be determined in an in vitro assay system. Such in vitro assay systems include assay such as the assays as described herein.More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group I member 2(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
Affinity DataIC50: 21nMAssay Description:PXR can be determined in an in vitro assay system. Such in vitro assay systems include assay such as the assays as described herein.More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group I member 2(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
Affinity DataIC50: 22nMAssay Description:PXR can be determined in an in vitro assay system. Such in vitro assay systems include assay such as the assays as described herein.More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group I member 2(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
Affinity DataIC50: 24nMAssay Description:PXR can be determined in an in vitro assay system. Such in vitro assay systems include assay such as the assays as described herein.More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group I member 2(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
Affinity DataIC50: 26nMAssay Description:PXR can be determined in an in vitro assay system. Such in vitro assay systems include assay such as the assays as described herein.More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group I member 2(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
Affinity DataIC50: 26nMAssay Description:PXR can be determined in an in vitro assay system. Such in vitro assay systems include assay such as the assays as described herein.More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group I member 2(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
Affinity DataIC50: 27nMAssay Description:PXR can be determined in an in vitro assay system. Such in vitro assay systems include assay such as the assays as described herein.More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group I member 2(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
Affinity DataIC50: 27nMAssay Description:PXR can be determined in an in vitro assay system. Such in vitro assay systems include assay such as the assays as described herein.More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group I member 2(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
Affinity DataIC50: 28nMAssay Description:PXR can be determined in an in vitro assay system. Such in vitro assay systems include assay such as the assays as described herein.More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group I member 2(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
Affinity DataIC50: 30nMAssay Description:PXR can be determined in an in vitro assay system. Such in vitro assay systems include assay such as the assays as described herein.More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group I member 2(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
Affinity DataIC50: 39nMAssay Description:PXR can be determined in an in vitro assay system. Such in vitro assay systems include assay such as the assays as described herein.More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group I member 2(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
Affinity DataIC50: 42nMAssay Description:PXR can be determined in an in vitro assay system. Such in vitro assay systems include assay such as the assays as described herein.More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group I member 2(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
Affinity DataIC50: 44nMAssay Description:PXR can be determined in an in vitro assay system. Such in vitro assay systems include assay such as the assays as described herein.More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group I member 2(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
Affinity DataIC50: 45nMAssay Description:PXR can be determined in an in vitro assay system. Such in vitro assay systems include assay such as the assays as described herein.More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group I member 2(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
Affinity DataIC50: 53nMAssay Description:PXR can be determined in an in vitro assay system. Such in vitro assay systems include assay such as the assays as described herein.More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group I member 2(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
Affinity DataIC50: 55nMAssay Description:PXR can be determined in an in vitro assay system. Such in vitro assay systems include assay such as the assays as described herein.More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group I member 2(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
Affinity DataIC50: 69nMAssay Description:PXR can be determined in an in vitro assay system. Such in vitro assay systems include assay such as the assays as described herein.More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group I member 2(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
Affinity DataIC50: 85nMAssay Description:PXR can be determined in an in vitro assay system. Such in vitro assay systems include assay such as the assays as described herein.More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group I member 2(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
Affinity DataIC50: 100nMAssay Description:PXR can be determined in an in vitro assay system. Such in vitro assay systems include assay such as the assays as described herein.More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group I member 2(Human)
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
ST. JUDE CHILDREN''S RESEARCH HOSPITAL
US Patent
Affinity DataIC50: 120nMAssay Description:PXR can be determined in an in vitro assay system. Such in vitro assay systems include assay such as the assays as described herein.More data for this Ligand-Target Pair
